Nitsche Ulrich, Friess Helmut, Agha Ayman, Angele Martin, Eckel Renate, Heitland Wolf, Jauch Karl-Walter, Krenz Detlef, Nüssler Natascha C, Rau Horst-Günter, Ruppert Reinhard, Schubert-Fritschle Gabriele, Wilhelm Dirk, Werner Jens, Engel Jutta
Klinik und Poliklinik für Chirurgie, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Straße 22, 81675, Munich, Germany.
Klinik für Allgemein-, Viszeral-, Gefäß- und Thoraxchirurgie, Klinikum München-Bogenhausen, Englschalkinger Str. 77, 81925, Munich, Germany.
J Cancer Res Clin Oncol. 2016 Nov;142(11):2357-66. doi: 10.1007/s00432-016-2224-2. Epub 2016 Aug 29.
Besides classical colorectal adenocarcinomas (AC), mucinous adenocarcinomas (MAC) and signet-ring cell carcinomas (SC) occur. Controversy remains regarding their prognostic role. Aim of this study was to define prognostic and histopathological specifications of mucinous and signet-ring cell colorectal cancer.
A total of 28,056 patients with AC, MAC, and SC between 1998 and 2012 in the catchment area of the Munich Cancer Registry were analyzed. Time to locoregional recurrence and distant recurrence was calculated by cumulative incidence. Survival was analyzed by the Kaplan-Meier method, calculation of relative survival, and Cox proportional hazards regression.
AC occurred in 25,172 patients (90 %), MAC in 2724 (9.7 %), and SC in 160 (0.6 %). AC were less frequently localized in the proximal colon (34 %) compared to MAC (57 %, p < 0.001) and SC (76 %, p < 0.001). Both, MAC and SC had higher T, N, and M categories, lymphatic invasion, and worse grading (p < 0.001 for each). There were significant differences regarding the 10-year cumulative incidence of locoregional recurrence (p < 0.001), and distant recurrence (p < 0.001). For AC, the 5-year overall survival was 59 % (95 % confidence interval 58.0; 59.3), for MAC 52 % (50.2; 54.2), and for SC 40 % (32.1; 48.5; p < 0.001). However, MAC or SC did not remain independent prognostic factors for overall survival compared to AC upon multivariable analysis (p = 0.981).
This large cohort reveals specific histopathological and recurrence patterns for patients with colorectal AC, MAC, and SC. MAC and SC are diagnosed at more advanced tumor stages and therefore entail reduced survival rates.
除了经典的结直肠腺癌(AC)外,还存在黏液腺癌(MAC)和印戒细胞癌(SC)。关于它们的预后作用仍存在争议。本研究的目的是确定黏液性和印戒细胞型结直肠癌的预后及组织病理学特征。
对1998年至2012年慕尼黑癌症登记处辖区内共28056例患有AC、MAC和SC的患者进行分析。局部区域复发和远处复发时间通过累积发病率计算。生存情况采用Kaplan-Meier法、相对生存率计算和Cox比例风险回归分析。
AC发生于25172例患者(90%),MAC发生于2724例(9.7%),SC发生于160例(0.6%)。与MAC(57%,p<0.001)和SC(76%,p<0.001)相比,AC较少定位于近端结肠(34%)。MAC和SC的T、N和M分期、淋巴浸润均更高,分级更差(每项p<0.001)。局部区域复发的10年累积发病率(p<0.001)和远处复发(p<0.001)存在显著差异。AC的5年总生存率为59%(95%置信区间58.0;59.3),MAC为52%(50.2;54.2),SC为40%(32.1;48.5;p<0.001)。然而,多变量分析显示,与AC相比,MAC或SC并非总生存的独立预后因素(p=0.981)。
这个大型队列揭示了结直肠AC、MAC和SC患者的特定组织病理学和复发模式。MAC和SC在更晚期肿瘤阶段被诊断出来,因此生存率降低。